Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature
Author(s) -
Fatehi Elzein,
Ahmed Ibrahim,
Fatimah Alshahrani,
Mervat Mahrous,
Esam Murshid,
Turki Aldhehyan,
Ghadah Almutiri,
Meshal Altowairqi,
Medina Ahmed,
Mohammed Alsaeed,
Eid Alsufyani,
Nouf Alnawshan
Publication year - 2021
Publication title -
journal of infection and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.983
H-Index - 35
eISSN - 1876-035X
pISSN - 1876-0341
DOI - 10.1016/j.jiph.2021.01.002
Subject(s) - medicine , asymptomatic , tocilizumab , covid-19 , dexamethasone , pulmonary embolism , etiology , pneumonia , disease , pediatrics , infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-cov-2), first described in December 2019, has now infected more than 28 million cases with almost one million deaths. Reinfection is not definitely established however disease recurrence is increasingly reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom